FibroBiologics, Inc. announced on November 24, 2025, a securities purchase agreement to sell approximately 4.48 million shares of common stock at $0.335 each, potentially raising about $1.5 million for working capital. Additionally, warrants for the same number of shares were issued, pending stockholder approval, which could raise another $1.5 million if exercised.